Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06701461 · ClinicalTrials.gov registry record · NA

Measurement of Osteoarthritic Patient Pain Through Electrodermal Activity Signals

A NA study, sponsored by Dartmouth-Hitchcock Medical Center.

Not yet
Registry status
NA
Development phase
15
Enrollment target

NCT06701461: Clinical Trial NA study, sponsored by Dartmouth-Hitchcock Medical Center.

NCT06701461 is a NA study that has not yet begun recruiting, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06701461, a NA study, has not yet begun recruiting, sponsored by Dartmouth-Hitchcock Medical Center.

NOT YET RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

This pilot study aims to investigate the viability of using a smartwatch-based electrodermal activity (EDA) sensor to capture enough EDA signal to quantitatively assess pain in osteoarthritis subjects and test the feasibility of its methods and procedures for later use in subsequent larger-scale studies.

Primary Outcome

As a pilot study, the goal is not hypothesis testing but rather examining the feasibility of this approach to measuring patient pain in osteoarthritic patients. Thus, the statistical analysis will be primarily descriptive. The baseline experiment is being done to see whether the smartwatch measurements are at all comparable to prior similar experiments using the thermal grill (Posada-Quintero 2016; Posada-Quintero 2021). For this reason, though not typical for a pilot study, participant response

Interventions

  • DEVICE Electrodermal Activity signal

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2026-08
Est. Completion 2026-10
Phase NA
Dartmouth-Hitchcock Medical Center

427 total trials

What is known before NCT06701461 opens enrollment

NCT06701461 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Electrodermal Activity signal is the first listed.

NCT06701461 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06701461 about?

NCT06701461 is a clinical study titled "Measurement of Osteoarthritic Patient Pain Through Electrodermal Activity Signals". This pilot study aims to investigate the viability of using a smartwatch-based electrodermal activity (EDA) sensor to capture enough EDA signal to quantitatively assess pain in osteoarthritis subjects and test the feasibility of its methods and procedures for later use in subsequent larger-scale stu...

What is the current status of trial NCT06701461?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2026-08. Estimated completion is 2026-10.

What interventions are being tested in trial NCT06701461?

The interventions under investigation include: Electrodermal Activity signal (DEVICE).

Who is sponsoring clinical trial NCT06701461?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06701461's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT06701461, the US trial registry maintained by the National Library of Medicine. NCT06701461 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.